Home
>
National Drug Code (NDC)
>
ARRANON
ARRANON - 0007-4401-06 - (nelarabine)
Drug Information of ARRANON
| Product NDC: | 0007-4401 |
| Proprietary Name: | ARRANON |
| Non Proprietary Name: | nelarabine |
| Active Ingredient(s): | 5 mg/mL & nbsp; nelarabine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ARRANON
| Product NDC: | 0007-4401 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021877 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060119 |
Package Information of ARRANON
| Package NDC: | 0007-4401-06 |
| Package Description: | 6 VIAL, GLASS in 1 CARTON (0007-4401-06) > 50 mL in 1 VIAL, GLASS (0007-4401-01) |
NDC Information of ARRANON
| NDC Code | 0007-4401-06 |
| Proprietary Name | ARRANON |
| Package Description | 6 VIAL, GLASS in 1 CARTON (0007-4401-06) > 50 mL in 1 VIAL, GLASS (0007-4401-01) |
| Product NDC | 0007-4401 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nelarabine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060119 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | NELARABINE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
